Morgan Stanley Simulations Plus, Inc. Transaction History
Morgan Stanley
- $1.59 Trillion
- Q3 2025
A detailed history of Morgan Stanley transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,297,423 shares of SLP stock, worth $22.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,297,423
Previous 801,635
61.85%
Holding current value
$22.5 Million
Previous $14 Million
39.78%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding SLP
# of Institutions
184Shares Held
17.5MCall Options Held
38.3KPut Options Held
27.7K-
Black Rock Inc. New York, NY2.46MShares$42.7 Million0.0% of portfolio
-
Tributary Capital Management, LLC1.14MShares$19.7 Million0.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA974KShares$16.9 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN768KShares$13.3 Million1.39% of portfolio
-
Rockefeller Capital Management L.P. New York, NY746KShares$12.9 Million0.02% of portfolio
About Simulations Plus, Inc.
- Ticker SLP
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 20,297,700
- Market Cap $351M
- Description
- Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...